| PERIOD ENDING | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | 30-Jun-07 | | Total Revenue | 5,994 | 3,479 | 2,841 | 4,717 | | Cost of Revenue | 7,052 | 22,030 | (840) | (3,983) | | | Gross Profit | (1,058) | (18,551) | 3,681 | 8,700 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,287 | (17,202) | 6,545 | 10,814 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (5,344) | (1,349) | (2,864) | (2,115) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (5,344) | (1,349) | (2,864) | (2,115) | | Interest Expense | 42 | 65 | 63 | 63 | | Income Before Tax | (5,386) | (1,414) | (2,927) | (2,178) | | Income Tax Expense | (1,813) | (729) | (969) | (590) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,573) | (685) | (1,958) | (1,588) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,573) | (685) | (1,958) | (1,588) | | Preferred Stock And Other Adjustments | (25) | (25) | (25) | (25) | | | Net Income Applicable To Common Shares | ($3,598) | ($710) | ($1,983) | ($1,613) |
|
0.47% Nasdaq 
Income Statement
